Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05798897
Title Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma (APOLLO)
Acronym APOLLO
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Marker Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Colorado Blood Cancer Institute (Sarah Cannon) RECRUITING Denver Colorado 80218 United States Details
University of Kansas Medical Center RECRUITING Kansas City Kansas 66160 United States Details
Cornell RECRUITING New York New York 10065 United States Details
Tennessee Oncology PLLC RECRUITING Nashville Tennessee 37203 United States Details
Sarah Cannon Research Institute at St. David's South Austin RECRUITING Austin Texas 78704 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field